MedTrace Logo

Outpatient Treatment of Severe and Enduring Anorexia Nervosa

NCT05708404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-02-01

No results posted yet for this study

Summary

Approximately 20-30 % of individuals with the eating disorder anorexia nervosa develop an enduring form of the illness. In this study a new treatment for patients with severe and enduring anorexia nervosa was described. The treatment is flexible and aims at enhancing quality of life. The participants consisted of all referrals resulting in an assessment or treatment period at the unit between May 2017 and May 2022. The study was a registry study. Information regarding patient characteristics, treatment goals, and the course of treatment was gathered from medical records.

Conditions

  • Anorexia

Interventions

BEHAVIORAL

Outpatient treatment of severe and enduring anorexia nervosa

A novel outpatient treatment of severe and enduring anorexia nervosa, aiming at enhancing quality of life and minimizing harm

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Jaana Suokas, Ph.D. · HUS Helsinki Central Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05708404 on ClinicalTrials.gov